Drug Development
The mission of the Graduate School of Drug Development is to cultivate a cadre of researchers and healthcare professionals who specialise in drug development, embracing a comprehensive approach that considers the entire life cycle of medications. This educational pursuit spans a wide array of disciplines, from foundational research to clinical applications, and encompasses both experimental and computational methodologies.
In pursuit of excellence in training, the Graduate School leverages the wealth of expertise found within the Masters programmes of the Faculty of Health and the Faculty of Science, forging close partnerships with numerous university research centers and teams. Furthermore, it fosters collaborations with hospitals and engages with stakeholders in the socio-economic sphere, particularly within the pharmaceutical industry. The overarching goal is to furnish students with a robust, hands-on education in the field of drug development.


Presentation
In an international context, the Graduate School of Drug Development collaborates closely with several French and European universities. Its programmes, primarily conducted in English, provide opportunities for students to earn dual degrees and/or receive Erasmus Mundus accreditation. It fosters strong connections with other graduate schools, including the École de Chimie Physique de Paris and the Graduate Schools of Innovative Therapies in Cancerology, Translational Bioinformatics, and One Health-Emerging Infectious Diseases.
The Graduate School of Drug Development attracts health science students, including veterinarians specialising in certain areas, as well as a diverse array of students from various higher education institutions. Its multidisciplinary approach allows individuals with scientific bachelor’s degrees in fields such as chemistry, biophysics, bioinformatics, biology, genetics, or related interdisciplinary fields, nationally and internationally, to enroll in its Master’s programmes.
Drawing on the expertise of the “Drug and Health Product Sciences,” “Nanomedicine,” “Toxicology-Ecotoxicology,” and “Bioinformatics: In Silico Drug Design” Master’s programmes offered by the Faculties of Health and Science, the Graduate School leverages its strengths in pharmaceuticals. This breadth of offerings is rare among universities, creating a dynamic and enriching learning environment enriched by the diverse backgrounds of its students.
Internship opportunities for Master’s students span across research units within Université Paris Cité and other French universities, as well as various prestigious institutes and laboratories (including INSERM, CNRS, IRD, Pasteur, Curie, CEA, and INRIA), pharmaceutical companies, and national drug agencies such as ANSM, ANSES, INERIS, INRS, and IRSN. These placements provide invaluable practical experience and networking opportunities within the drug development field.
Additionally, the Graduate School of Drug Development offers a range of sandwich courses designed to facilitate apprenticeship integration and foster closer ties with industry partners.
Contact
Anne-Claude CAMPROUX
anne-claude.camproux@u-paris-fr
Catherine MARCHAND-LEROUX
catherine.marchand@u-paris.fr
Michel VIDAL
michel.vidal@u-paris-fr
Masters
The Graduate School of Drug Development is mainly supported by masters degrees from the Faculties of Health and Science. The courses are taught in French and English.
- Drug development and health products:
- Biomolecular engineering
- Health products quality assurance
- Integrating preclinical and clinical pharmacology
- Medicinal chemistry and molecular pharmacology
- Pharmaceutics and innovative therapies
- Pharmacokinetics and pharmacotechnics
- Pharmacology and pharmaceutical chemistry
- Therapeutics – from design to application of health products
Research
To fulfill the academic and professional standards of the pharmaceutical sector, the Graduate School of Drug Development is dedicated to equipping students with the necessary training and expertise for success in research or the workforce.
Benefiting from a robust national and international network, the Graduate School provides diverse internship opportunities in academic and industrial environments. Industry professionals actively participate in course development by teaching in both Master’s and doctoral programmes. Moreover, the Graduate School of Drug Development hosts regular seminars and scientific events within its doctoral schools, fostering a forum for knowledge exchange and collaboration.
Laboratories
Due to its expansive scope, the Graduate School of Drug Development collaborates with numerous partner laboratories on both national and international scales. Leveraging this extensive network, which includes esteemed scientists, the school offers students unparalleled access to top-tier expertise across various disciplines. This diversified network opens doors to a wide array of internship opportunities, spanning academic and industrial settings alike.
Committed to equipping students with the requisite training and skills to address the evolving demands of both academia and the private sector within the pharmaceutical field, the Graduate School works closely with its associated Research Units (UMR) through collaborative doctoral schools.
For a comprehensive overview of the involved laboratories, please refer to the following links:
Doctoral schools
Thanks to the wide range of themes covered by the pharmaceutical field , students can join a number of doctoral schools of Université Paris Cité:
- 3C – Brain, cognition, behaviour (DS 158)
- BioSPC – Bio Sorbonne Paris Cité (DS 562)
- FIRE – Frontières de l’Innovation en Recherche et Éducation (DS 474)
- HOB – Hematology, oncogenesis and biotherapies (DS 561)
- MTCI – Médicament, Toxicologie, Chimie, Imageries (DS 563)
- Pierre Louis de Santé Publique, Epidémiologie et Sciences de l’Information Biomédicale (DS 393)
Executives
The Graduate School of Drug Development is managed by:
- Prof. Anne-Claude CAMPROUX
Faculty of Science - Prof. Michel VIDAL
Faculty of Health
The steering committee of the Graduate School is formed by:
- Karine ANDRIEUX
- Armelle BAEZA
- Valérie BESSON-CORDONNIER
- Xavier COUMOUL
- Ludovic JEAN
- Olivier TABOUREAU
À lire aussi

Hypertension artérielle : prévenir pour mieux soigner
À l’occasion de la Journée mondiale de l’hypertension artérielle, l’Université Paris Cité met en lumière les travaux de l’unité de recherche Paris Cardiovascular Research Center (PARCC) et les actions de sensibilisation menées pour lutter contre cette maladie silencieuse, première cause de mortalité évitable dans le monde.

The Society and Health Graduate School provides support for the implementation of scientific and training projects.
The Graduate School would like to help young researchers at the Université Paris Cité to implement their scientific and training projects. The aim of this call for applications is to provide financial support for projects and actions that will help structure their research work. Doctoral students must apply for funding before June 30, 2025.

La Graduate School Society and Health propose une aide à la mise en œuvre de projets scientifiques et de formation
La Graduate School souhaite aider les jeunes chercheuses et chercheurs de l’Université Paris Cité dans la mise en œuvre de leurs projets scientifiques et de formation. Cet appel vise à les soutenir financièrement dans la réalisation de projets et d’actions structurants pour leurs travaux de recherche. Les doctorantes et doctorants doivent déposer leur demande de financement avant le 30 juin 2025.
![[Circle U.] Immersion au cœur du climat – exposition virtuelle](https://u-paris.fr/wp-content/uploads/2025/05/La-France-en-2100-1080x675.jpg)
[Circle U.] Immersion au cœur du climat – exposition virtuelle
L'alliance européenne Circle U., dont l'Université Paris Cité fait partie, vous invite à découvrir le regards de sa communauté sur le Climat. Au travers d'une exposition photographie, Circle U. vous propose une balade virtuelle au cœur de notre planète...